Skip to main content
Clinical Trials/NCT05857488
NCT05857488
Terminated
Not Applicable

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at University of Virginia (UVa)

Massachusetts General Hospital1 site in 1 country1 target enrollmentJanuary 1, 2022
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Massachusetts General Hospital
Enrollment
1
Locations
1
Primary Endpoint
Ability to Acquire Intestinal Images in an Unsedated Infant
Status
Terminated
Last Updated
8 months ago

Overview

Brief Summary

The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.

Detailed Description

A total of fifteen (15) subjects, infants 6 months of age to 48 months of age will be enrolled in this study. While the subject is awake and unseated, a catheter with optical coherence tomography (OCT) imaging technology will be introduced transnasally. Images will be acquired while the tube is moved through the subject's GI tract. After imaging is complete, accessory device(s) may be threaded through the catheter to collect samples of the gut microbiome and/or measure intestinal potential difference.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
June 17, 2022
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Guillermo Tearney

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • 6 to 48 month old infants that can follow fasting requirements

Exclusion Criteria

  • Any infant under 6kg of weight since this is the minimum weight for 6.5 F nasogastric (NG) tube
  • Any infant whose nasal passage cannot reasonably accommodate a 6.5 French nasoduodenal catheter.
  • Any infants with absolute or relative contraindications to transnasal tubes:
  • severe midface trauma and recent nasal, throat, or esophageal surgery.
  • Esophageal varices, esophageal stricture, and alkaline ingestion
  • Congenital anatomical defects affecting the gastrointestinal tract, most specifically cleft lip and/or cleft palate.
  • Any infant with absolute or relative contraindication to a duodenal biopsy:
  • post bone marrow transplant
  • coagulation abnormalities

Outcomes

Primary Outcomes

Ability to Acquire Intestinal Images in an Unsedated Infant

Time Frame: Approximate 90 minute study visit

Can the technology successfully collect images of the small intestine in an unseated infant?

Ability for Unsedated Infant Subjects to Tolerate the Device

Time Frame: Approximate 90 minute study visit

Can the unsedated infant subjects tolerate the administration of the device with minimal discomfort?

Ability to Visualize Features of the Small Intestine in Unsedated Infants.

Time Frame: Approximate 90 minute study visit

Can the technology successfully visualize features of the small intestine (villi etc) on OCT in unsedated infants?

Ability to Acquire Microbiome Brush and Intestinal Potential Difference Samples

Time Frame: Approximate 90 minute study visit

Can the technology successfully collect microbiome brush and/or intestinal potential differences samples?

Secondary Outcomes

  • Amount and Composition of Microbial Samples Acquired Via Microbiome Brush Sampling in Unsedated Infants(Approximate 90 minute study visit)
  • Ability to Collect Intestinal Potential Difference Measurements in Various Locations in the Gastrointestinal Tract of Unsedated Infants(Approximate 90 minute study visit)

Study Sites (1)

Loading locations...

Similar Trials